These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 37490989)
1. Enhancing NKT cell-mediated immunity against hepatocellular carcinoma: Role of XYXD in promoting primary bile acid synthesis and improving gut microbiota. Deng Z; Ouyang Z; Mei S; Zhang X; Li Q; Meng F; Hu Y; Dai X; Zhou S; Mao K; Huang C; Dai J; Yi C; Tan N; Feng T; Long H; Tian X J Ethnopharmacol; 2024 Jan; 318(Pt B):116945. PubMed ID: 37490989 [TBL] [Abstract][Full Text] [Related]
2. Hepatoprotective effect of Xiayuxue decoction ethyl acetate fraction against carbon tetrachloride-induced liver fibrosis in mice via inducing apoptosis and suppressing activation of hepatic stellate cells. Zhang D; Zhang L; Chen G; Xu Y; Yang H; Xiao Z; Chen J; Mu Y; Zhang H; Liu W; Liu P Pharm Biol; 2020 Dec; 58(1):1229-1243. PubMed ID: 33332219 [TBL] [Abstract][Full Text] [Related]
3. Tong-Xie-Yao-Fang strengthens intestinal feedback control of bile acid synthesis to ameliorate irritable bowel syndrome by enhancing bile salt hydrolase-expressing microbiota. Jia F; Du L; He J; Zhang Z; Hou X; Dong Q; Bian Z; Zhao L J Ethnopharmacol; 2024 Sep; 331():118256. PubMed ID: 38677571 [TBL] [Abstract][Full Text] [Related]
4. Abnormal bile acid-microbiota crosstalk promotes the development of hepatocellular carcinoma. Shen R; Ke L; Li Q; Dang X; Shen S; Shen J; Li S; Liang L; Peng B; Kuang M; Ma Y; Yang Z; Hua Y Hepatol Int; 2022 Apr; 16(2):396-411. PubMed ID: 35211843 [TBL] [Abstract][Full Text] [Related]
5. Xiayuxue Decoction ([symbols; see text]) attenuates hepatic stellate cell activation and sinusoidal endothelium defenestration in CCl4-induced fibrotic liver of mice. Zhang LJ; Sun MY; Ning BB; Zhang WM; Chen GF; Mu YP; Zhang H; Liu J; Bian YQ; Liu P Chin J Integr Med; 2014 Jul; 20(7):516-23. PubMed ID: 24972579 [TBL] [Abstract][Full Text] [Related]
6. Regulatory effect of Yinchenhao decoction on bile acid metabolism to improve the inflammatory microenvironment of hepatocellular carcinoma in mice. Shi J; Zhu L; Tang BY; Yang WQ; Xi SY; Zhang CL; Li PF; Wang YJ; Guo KH; Huang JR; Huang CR; Yu ZX; Yu BK; Zhang CF; Zhang YM J Nat Med; 2024 Jun; 78(3):633-643. PubMed ID: 38704807 [TBL] [Abstract][Full Text] [Related]
7. Investigating the molecular mechanism of Qizhu anticancer prescription in inhibiting hepatocellular carcinoma based on high-resolution mass spectrometry and network pharmacology. Sun J; Ma M; Zhong X; Li J; Yi J; Zhang R; Liu X; Peng L; Sun X; Feng W; Hu R; Huang Q; Lv M; Fan K; Zhou X J Ethnopharmacol; 2024 Jun; 328():117985. PubMed ID: 38417600 [TBL] [Abstract][Full Text] [Related]
8. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice. Li X; Zhao W; Xiao M; Yu L; Chen Q; Hu X; Zhao Y; Xiong L; Chen X; Wang X; Ba Y; Guo Q; Wu X J Ethnopharmacol; 2022 Aug; 294():115333. PubMed ID: 35500802 [TBL] [Abstract][Full Text] [Related]
9. Identification of the molecular targets and mechanisms of compound mylabris capsules for hepatocellular carcinoma treatment through network pharmacology and bioinformatics analysis. Wei J; Ma L; Liu W; Wang Y; Shen C; Zhao X; Zhao C J Ethnopharmacol; 2021 Aug; 276():114174. PubMed ID: 33932512 [TBL] [Abstract][Full Text] [Related]
10. Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice. Li Q; Li M; Li F; Zhou W; Dang Y; Zhang L; Ji G J Ethnopharmacol; 2020 Aug; 258():112896. PubMed ID: 32325178 [TBL] [Abstract][Full Text] [Related]
11. Yupingfeng San exhibits anticancer effect in hepatocellular carcinoma cells via the MAPK pathway revealed by HTS Pei T; Dai Y; Tan X; Geng A; Li S; Gui Y; Hu C; An J; Yu X; Bao X; Wang D J Ethnopharmacol; 2023 Apr; 306():116134. PubMed ID: 36627003 [TBL] [Abstract][Full Text] [Related]
12. Dahuang Zhechong pill attenuates hepatic sinusoidal capillarization in liver cirrhosis and hepatocellular carcinoma rat model via the MK/integrin signaling pathway. Fu C; Zhang Y; Xi WJ; Xu K; Meng F; Ma T; Li W; Wu L; Chen Z J Ethnopharmacol; 2023 May; 308():116191. PubMed ID: 36731809 [TBL] [Abstract][Full Text] [Related]
13. Cholecystohepatic shunt pathway reduces secondary bile acid accumulation to enhance natural killer T cell-mediated anti-hepatocellular carcinoma immunity. Liu S; Gou H; Wei H; Chen S; Zhuo S; Luo M; Qin S; Zhang M; Chen J; Huang Z; Xia X; Yang X; He K J Gastroenterol Hepatol; 2024 Aug; 39(8):1684-1694. PubMed ID: 38747068 [TBL] [Abstract][Full Text] [Related]
14. [Mechanism of Bupleurum scorzonerifolium and Paeonia lactiflora herbal pair against liver cancer: an exploration based on UPLC-Q-TOF-MS combined with network pharmacology]. Zou X; Sui Y; Tang XY; Zhang R; Shu Q; Gong T; Wu S; Sun ZW; Li WL; Qu ZY Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(13):3597-3608. PubMed ID: 35850814 [TBL] [Abstract][Full Text] [Related]
15. Disease-Associated Gut Microbiota Reduces the Profile of Secondary Bile Acids in Pediatric Nonalcoholic Fatty Liver Disease. Yu J; Zhang H; Chen L; Ruan Y; Chen Y; Liu Q Front Cell Infect Microbiol; 2021; 11():698852. PubMed ID: 34568090 [TBL] [Abstract][Full Text] [Related]
16. D-glucaro-1,4-lactone improves Diethylnitrosamine induced hepatocellular carcinoma in rats via the uric acid-ROS pathway. Cai H; Zhang Y; Wang J; Deng Y; Liu J; Wu Z; Cao D; Song Z; Wang L; Xie B J Ethnopharmacol; 2024 Nov; 334():118569. PubMed ID: 38996947 [TBL] [Abstract][Full Text] [Related]
17. Multi-material basis and multi-mechanisms of the Dahuang Zhechong pill for regulating Treg/Th1 balance in hepatocellular carcinoma. Wu L; Yang FR; Xing ML; Lu SF; Chen HL; Yang QW; Zhang YT; Lu Y; Huang Y Phytomedicine; 2022 Jun; 100():154055. PubMed ID: 35344716 [TBL] [Abstract][Full Text] [Related]
18. Scutellariae radix and coptidis rhizoma ameliorate glycolipid metabolism of type 2 diabetic rats by modulating gut microbiota and its metabolites. Xiao S; Liu C; Chen M; Zou J; Zhang Z; Cui X; Jiang S; Shang E; Qian D; Duan J Appl Microbiol Biotechnol; 2020 Jan; 104(1):303-317. PubMed ID: 31758238 [TBL] [Abstract][Full Text] [Related]
19. Effects of Xian-Ling-Gu-Bao capsule on the gut microbiota in ovariectomized rats: Metabolism and modulation. Tang XY; Gao MX; Xiao HH; Dai ZQ; Yao ZH; Dai Y; Yao XS J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1176():122771. PubMed ID: 34058528 [TBL] [Abstract][Full Text] [Related]
20. Metabolomic study of the intervention effects of Shuihonghuazi Formula, a Traditional Chinese Medicinal formulae, on hepatocellular carcinoma (HCC) rats using performance HPLC/ESI-TOF-MS. Bao Y; Wang S; Yang X; Li T; Xia Y; Meng X J Ethnopharmacol; 2017 Feb; 198():468-478. PubMed ID: 28108381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]